ID   KCD11_HUMAN             Reviewed;         232 AA.
AC   Q693B1; B3KPE0;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   18-JUN-2025, entry version 153.
DE   RecName: Full=BTB/POZ domain-containing protein KCTD11;
DE   AltName: Full=KCASH1 protein {ECO:0000303|PubMed:21472142};
DE   AltName: Full=Potassium channel tetramerization domain-containing protein 11;
DE   AltName: Full=RING-type E3 ubiquitin transferase subunit KCTD11 {ECO:0000303|PubMed:20081843};
GN   Name=KCTD11; Synonyms=C17orf36, REN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   CHARACTERIZATION OF BTB DOMAIN, AND ROLE IN MEDULLOBLASTOMA DEVELOPMENT.
RX   PubMed=15249678; DOI=10.1073/pnas.0400690101;
RA   Di Marcotullio L., Ferretti E., De Smaele E., Argenti B., Mincione C.,
RA   Zazzeroni F., Gallo R., Masuelli L., Napolitano M., Maroder M., Modesti A.,
RA   Giangaspero F., Screpanti I., Alesse E., Gulino A.;
RT   "REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human
RT   medulloblastoma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:10833-10838(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ALTERNATIVE INITIATION,
RP   USE OF A NON-AUG INITIATOR START CODON, SUBUNIT, AND INTERACTION WITH CUL3.
RX   PubMed=21237243; DOI=10.1016/j.biochi.2010.12.014;
RA   Correale S., Pirone L., Di Marcotullio L., De Smaele E., Greco A.,
RA   Mazza D., Moretti M., Alterio V., Vitagliano L., Di Gaetano S., Gulino A.,
RA   Pedone E.M.;
RT   "Molecular organization of the cullin E3 ligase adaptor KCTD11.";
RL   Biochimie 93:715-724(2011).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION IN UBIQUITINATION OF HDAC1.
RX   PubMed=20081843; DOI=10.1038/ncb2013;
RA   Canettieri G., Di Marcotullio L., Greco A., Coni S., Antonucci L.,
RA   Infante P., Pietrosanti L., De Smaele E., Ferretti E., Miele E.,
RA   Pelloni M., De Simone G., Pedone E.M., Gallinari P., Giorgi A.,
RA   Steinkuhler C., Vitagliano L., Pedone C., Schinin M.E., Screpanti I.,
RA   Gulino A.;
RT   "Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay
RT   regulates Hedgehog signalling through Gli acetylation.";
RL   Nat. Cell Biol. 12:132-142(2010).
RN   [7]
RP   SUBUNIT.
RX   PubMed=21472142; DOI=10.1593/neo.101630;
RA   De Smaele E., Di Marcotullio L., Moretti M., Pelloni M., Occhione M.A.,
RA   Infante P., Cucchi D., Greco A., Pietrosanti L., Todorovic J., Coni S.,
RA   Canettieri G., Ferretti E., Bei R., Maroder M., Screpanti I., Gulino A.;
RT   "Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3
RT   adaptors suppressing histone deacetylase and Hedgehog activity in
RT   medulloblastoma.";
RL   Neoplasia 13:374-385(2011).
RN   [8]
RP   INTERACTION WITH CUL3.
RX   PubMed=25974686; DOI=10.1371/journal.pone.0126808;
RA   Smaldone G., Pirone L., Balasco N., Di Gaetano S., Pedone E.M.,
RA   Vitagliano L.;
RT   "Cullin 3 recognition is not a universal property among KCTD proteins.";
RL   PLoS ONE 10:E0126808-E0126808(2015).
RN   [9]
RP   PENTAMERIZATION, AND ELECTRON MICROSCOPY OF THE OLIGOMERIZED BTB DOMAIN.
RX   PubMed=27152988; DOI=10.1002/1873-3468.12203;
RA   Smaldone G., Pirone L., Pedone E., Marlovits T., Vitagliano L.,
RA   Ciccarelli L.;
RT   "The BTB domains of the potassium channel tetramerization domain proteins
RT   prevalently assume pentameric states.";
RL   FEBS Lett. 590:1663-1671(2016).
CC   -!- FUNCTION: Plays a role as a marker and a regulator of neuronal
CC       differentiation; Up-regulated by a variety of neurogenic signals, such
CC       as retinoic acid, epidermal growth factor/EGF and NGFB/nerve growth
CC       factor. Induces apoptosis, growth arrest and the expression of cyclin-
CC       dependent kinase inhibitor CDKN1B. Plays a role as a tumor repressor
CC       and inhibits cell growth and tumorigenicity of medulloblastoma (MDB).
CC       Acts as a probable substrate-specific adapter for a BCR (BTB-CUL3-RBX1)
CC       E3 ubiquitin-protein ligase complex towards HDAC1. Functions as
CC       antagonist of the Hedgehog pathway on cell proliferation and
CC       differentiation by affecting the nuclear transfer of transcription
CC       factor GLI1, thus maintaining cerebellar granule cells in
CC       undifferentiated state, this effect probably occurs via HDAC1 down-
CC       regulation, keeping GLI1 acetylated and inactive. When knock-down,
CC       Hedgehog antagonism is impaired and proliferation of granule cells is
CC       sustained. Activates the caspase cascade. {ECO:0000269|PubMed:15249678,
CC       ECO:0000269|PubMed:20081843, ECO:0000269|PubMed:21237243}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homopentamer. Interacts with KCTD6 and KCTD21; KCTD11 and
CC       KCTD6 or KCTD21 may associate in pentameric assemblies. Component of
CC       the BCR(KCTD11) E3 ubiquitin ligase complex, at least composed of CUL3
CC       and KCTD11 and RBX1. Interacts (via BTB domain) with CUL3; initially a
CC       4:4 stoichiometry has been reported, however, electron microscopy
CC       revealed pentameric states of the BTB domain.
CC       {ECO:0000269|PubMed:21237243, ECO:0000269|PubMed:21472142,
CC       ECO:0000269|PubMed:25974686, ECO:0000269|PubMed:27152988}.
CC   -!- INTERACTION:
CC       Q693B1; Q693B1: KCTD11; NbExp=2; IntAct=EBI-12552177, EBI-12552177;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1; Synonyms=sKCTD11;
CC         IsoId=Q693B1-1; Sequence=Displayed;
CC       Name=2; Synonyms=lKCTD11;
CC         IsoId=Q693B1-2; Sequence=VSP_044086;
CC   -!- TISSUE SPECIFICITY: Higher expression in cerebellum than in whole brain
CC       and lower expression in medulloblastoma. {ECO:0000269|PubMed:15249678}.
CC   -!- DOMAIN: The BTB domain is required for growth-suppressing properties.
CC   -!- MISCELLANEOUS: Haploinsufficiency of KCTD11 may be a cause of
CC       development of medulloblastoma (MDB). MDB is a malignant, invasive
CC       embryonal tumor of the cerebellum with a preferential manifestation in
CC       children. An allelic deletion involving genes from chromosome region
CC       17p11.2-pter, sometimes restricted to 17p13.2-13.3, occurs in up to 50%
CC       of MDB.
CC   -!- MISCELLANEOUS: [Isoform 2]: Non-AUG start codon. {ECO:0000305}.
CC   -!- CAUTION: A N-terminal fragment of KCTD11 isoform 2 (comprising residues
CC       15 - 115) has been used for some KCTD11:CUL3 interaction studies.
CC       {ECO:0000269|PubMed:25974686}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY646650; AAT75307.1; -; mRNA.
DR   EMBL; AK056227; BAG51652.1; -; mRNA.
DR   EMBL; CH471108; EAW90208.1; -; Genomic_DNA.
DR   EMBL; BC110598; AAI10599.1; -; mRNA.
DR   CCDS; CCDS32545.1; -. [Q693B1-1]
DR   CCDS; CCDS92247.1; -. [Q693B1-2]
DR   RefSeq; NP_001002914.1; NM_001002914.3. [Q693B1-1]
DR   RefSeq; NP_001350571.1; NM_001363642.1. [Q693B1-2]
DR   AlphaFoldDB; Q693B1; -.
DR   SMR; Q693B1; -.
DR   BioGRID; 127031; 7.
DR   CORUM; Q693B1; -.
DR   FunCoup; Q693B1; 19.
DR   IntAct; Q693B1; 2.
DR   MINT; Q693B1; -.
DR   STRING; 9606.ENSP00000495203; -.
DR   BindingDB; Q693B1; -.
DR   ChEMBL; CHEMBL4630837; -.
DR   GlyGen; Q693B1; 2 sites.
DR   iPTMnet; Q693B1; -.
DR   PhosphoSitePlus; Q693B1; -.
DR   BioMuta; KCTD11; -.
DR   DMDM; 74708977; -.
DR   MassIVE; Q693B1; -.
DR   PaxDb; 9606-ENSP00000328352; -.
DR   PeptideAtlas; Q693B1; -.
DR   ProteomicsDB; 66150; -. [Q693B1-1]
DR   Antibodypedia; 11945; 125 antibodies from 24 providers.
DR   DNASU; 147040; -.
DR   Ensembl; ENST00000333751.8; ENSP00000328352.5; ENSG00000213859.8. [Q693B1-2]
DR   Ensembl; ENST00000576980.2; ENSP00000495203.1; ENSG00000213859.8. [Q693B1-1]
DR   Ensembl; ENST00000672140.1; ENSP00000500224.1; ENSG00000288399.2. [Q693B1-1]
DR   Ensembl; ENST00000673447.2; ENSP00000500427.2; ENSG00000288399.2. [Q693B1-2]
DR   GeneID; 147040; -.
DR   KEGG; hsa:147040; -.
DR   MANE-Select; ENST00000333751.8; ENSP00000328352.5; NM_001363642.1; NP_001350571.1. [Q693B1-2]
DR   UCSC; uc002gge.5; human. [Q693B1-1]
DR   AGR; HGNC:21302; -.
DR   CTD; 147040; -.
DR   DisGeNET; 147040; -.
DR   GeneCards; KCTD11; -.
DR   HGNC; HGNC:21302; KCTD11.
DR   HPA; ENSG00000213859; Low tissue specificity.
DR   MIM; 609848; gene.
DR   OpenTargets; ENSG00000213859; -.
DR   VEuPathDB; HostDB:ENSG00000213859; -.
DR   eggNOG; KOG2723; Eukaryota.
DR   GeneTree; ENSGT00940000162799; -.
DR   HOGENOM; CLU_088122_0_0_1; -.
DR   InParanoid; Q693B1; -.
DR   OMA; FRLEWAP; -.
DR   OrthoDB; 2414723at2759; -.
DR   PAN-GO; Q693B1; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; Q693B1; -.
DR   PathwayCommons; Q693B1; -.
DR   SignaLink; Q693B1; -.
DR   SIGNOR; Q693B1; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 147040; 13 hits in 1155 CRISPR screens.
DR   GenomeRNAi; 147040; -.
DR   Pharos; Q693B1; Tchem.
DR   PRO; PR:Q693B1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q693B1; protein.
DR   Bgee; ENSG00000213859; Expressed in lower esophagus mucosa and 97 other cell types or tissues.
DR   ExpressionAtlas; Q693B1; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007406; P:negative regulation of neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0014016; P:neuroblast differentiation; IEA:Ensembl.
DR   GO; GO:0007405; P:neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.
DR   FunFam; 3.30.710.10:FF:000121; BTB/POZ domain-containing protein KCTD11; 1.
DR   Gene3D; 3.30.710.10; Potassium Channel Kv1.1, Chain A; 1.
DR   InterPro; IPR045763; KCTD11/21_C.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   PANTHER; PTHR14499:SF7; BTB_POZ DOMAIN-CONTAINING PROTEIN KCTD11; 1.
DR   PANTHER; PTHR14499; POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF19329; KCTD11_21_C; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   neXtProt; NX_Q693B1; -.
DR   PharmGKB; PA134890547; -.
DR   TreeFam; TF315332; -.
PE   1: Evidence at protein level;
KW   Alternative initiation; Cell cycle; Developmental protein;
KW   Growth regulation; Proteomics identification; Reference proteome;
KW   Transferase; Tumor suppressor; Ubl conjugation pathway.
FT   CHAIN           1..232
FT                   /note="BTB/POZ domain-containing protein KCTD11"
FT                   /id="PRO_0000248591"
FT   DOMAIN          1..49
FT                   /note="BTB"
FT   VAR_SEQ         1
FT                   /note="M -> MSPPPVPSSPPSFGGPVTLNVGGTLYSTTLETLTRFPDSM (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:21237243"
FT                   /id="VSP_044086"
FT   VARIANT         22
FT                   /note="G -> S (in dbSNP:rs8080182)"
FT                   /id="VAR_027354"
SQ   SEQUENCE   232 AA;  25887 MW;  7F075902E4259B2D CRC64;
     MLGAMFRAGT PMPPNLNSQG GGHYFIDRDG KAFRHILNFL RLGRLDLPRG YGETALLRAE
     ADFYQIRPLL DALRELEASQ GTPAPTAALL HADVDVSPRL VHFSARRGPH HYELSSVQVD
     TFRANLFCTD SECLGALRAR FGVASGDRAE GSPHFHLEWA PRPVELPEVE YGRLGLQPLW
     TGGPGERREV VGTPSFLEEV LRVALEHGFR LDSVFPDPED LLNSRSLRFV RH
//
